Related Experiment Video
Updated: Jan 28, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
Kristine Bech Holte1, Mona Svanteson2, Kristian Folkvord Hanssen3
1Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Insights
Long-term type 1 diabetes (T1D) survivors have a high prevalence of undiagnosed obstructive coronary artery disease (CAD). Poor glycemic control (HbA1c) and high LDL cholesterol are linked to CAD development in T1D.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Type 1 diabetes (T1D) is associated with an increased risk of cardiovascular complications.
- Long-term T1D survivors may face a higher burden of coronary artery disease (CAD).
- Understanding CAD prevalence and risk factors in T1D is crucial for preventative strategies.
Purpose of the Study:
- To determine the prevalence of obstructive CAD, undiagnosed CAD, and absent CAD in long-term T1D patients compared to controls.
- To investigate the association of mean HbA1c, LDL-cholesterol, and blood pressure over 2-3 decades with CAD in T1D.
- To assess CAD in individuals with a T1D duration of at least 45 years.
Main Methods:
- A cohort of T1D patients diagnosed before 1970 and age- and sex-matched controls were included.
- Longitudinal data (20-30 years) on HbA1c, LDL-cholesterol, and blood pressure were collected.
- Computed Tomography Coronary Angiography (CTCA) was used to assess coronary stenosis in participants without prior diagnoses.
Main Results:
- The prevalence of undiagnosed obstructive CAD was significantly higher in T1D patients (24%) compared to controls (10%).
- Absent CAD was more common in controls (50%) than in T1D patients (16%).
- Elevated mean HbA1c was associated with undiagnosed obstructive CAD (OR 2.30), and mean LDL-cholesterol was inversely associated with absent CAD (OR 0.12).
Conclusions:
- A substantial proportion (24%) of long-term T1D survivors exhibit undiagnosed obstructive CAD.
- Mean HbA1c and LDL-cholesterol levels are significant predictors of CAD in individuals with long-standing T1D.
- These findings highlight the importance of rigorous cardiovascular risk factor management in T1D.
Aims:
We studied the total prevalence of obstructive coronary artery disease (CAD), undiagnosed CAD and absent CAD in persons with ≥45-year duration of type 1 diabetes (T1D) versus controls, and associations with mean HbA1c, LDL-cholesterol and blood pressure over 2-3 decades.
Methods:
We included 76% (n = 103) of all persons with T1D diagnosed ≤1970 attending a diabetes center and 63 controls without diabetes. We collected 20-30 years of HbA1c, LDL-cholesterol and blood pressure measurements. Participants without previously diagnosed coronary heart disease (CHD) underwent Computed Tomography Coronary Angiography (CTCA). Undiagnosed obstructive CAD was defined as any coronary stenosis >50% on CTCA, absent CAD as no detected plaque, and total obstructive CAD as either obstructive CAD on CTCA or previous CHD diagnosis.
Results:
The prevalence of undiagnosed, absent and obstructive CAD was 24% (21/88), 16% (14/88) and 35% (36/103) in T1D versus 10% (6/60), 50% (30/60) and 14% (9/63) in controls (all p < 0.05). Mean HbA1c was associated with undiagnosed obstructive CAD (OR 2.30 95% C.I. 1.13-4.69), while mean LDL-cholesterol was inversely associated with absent CAD (0.12, 0.04-0.43).
Conclusions:
The prevalence of undiagnosed obstructive CAD was high (24%) in this cohort of long-term survivors with T1D. Mean LDL-cholesterol and HbA1c were associated with CAD.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Diabetes Mellitus: Type 2 and Gestational